November 5, 2015 Synthetic Biologics Reports Third Quarter 2015 Financial Results and Operational Highlights
October 21, 2015 Grant Awarded to Synthetic Biologics' Academic Collaborator to Fund Further Evaluation of Monoclonal Antibody for the Prevention of Whooping Cough (Pertussis)
October 20, 2015 Synthetic Biologics' Novel Irritable Bowel Syndrome with Constipation (IBS-C) Program Featured in American College of Gastroenterology Poster
October 8, 2015 Synthetic Biologics Initiates Second SYN-010 Phase 2 Clinical Trial Intended to Treat Irritable Bowel Syndrome with Constipation (IBS-C)
October 1, 2015 Synthetic Biologics Appoints Raymond Stapleton, PhD, as Senior Vice President, Manufacturing
September 21, 2015 Synthetic Biologics Reports First Analysis Demonstrating SYN-004's Ability to Protect the Microbiome from Damage Caused by IV Antibiotics in a Humanized Pig Model
August 10, 2015 Synthetic Biologics Reports Second Quarter 2015 Financial Results and Operational Highlights
August 10, 2015 Intrexon and Synthetic Biologics Enter ECC to Develop Novel Biotherapeutics for Treatment of Phenylketonuria
